Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Accuracy of the Bayley-II mental development index at 2 years as a predictor of cognitive impairment at school age among children born extremely preterm

Abstract

Objective

To describe the accuracy of the Bayley Scales of Infant Development-Second Edition (BSID-II) Mental Development Index (MDI) at 2 years of age for prediction of cognitive function at school age of children born extremely preterm.

Design

Study participants were enrolled in the Extremely Low Gestational Age Newborn Study between 2002 and 2004. Two-thirds of surviving children (n = 795) were assessed at 2 years with the BSID-II and at 10 years with an intelligence quotient (IQ) test. We computed test characteristics for a low MDI (<70), including predictive value positive.

Results

Almost two-thirds of children with a low MDI had a normal IQ (≥ 70) at 10 years. Concordance between MDI and IQ was highest among children with major motor and/or sensory impairment, and when MDI was adjusted for gestational age.

Conclusion

Most children born extremely preterm with low BSID-II MDI at 2 years have normal intelligence at school age.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. O’Shea TM, Allred EN, Dammann O, Hirtz D, Kuban KCK, Paneth N, et al. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev. 2009;85:719–25.

    Article  Google Scholar 

  2. Serenius F, Kallen K, Blennow M, Ewald U, Fellman V, Holmstrom G, et al. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. J Am Med Assoc. 2013;309:1810–20.

    Article  CAS  Google Scholar 

  3. Johnson S, Fawke J, Hennessy E, Rowell V, Thomas S, Wolke D, et al. Neurodevelopmental disability through 11 years of age in children born before 26 weeks of gestation. Pediatrics. 2009;124:E249–57.

    Article  Google Scholar 

  4. Helderman JB, O’Shea TM, Kuban KCK, Allred EN, Hecht JL, Dammann O, et al. Antenatal antecedents of cognitive impairment at 24 months in extremely low gestational age newborns. Pediatrics. 2012;129:494–502.

    Article  Google Scholar 

  5. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD, National Institute of Child H. Intensive care for extreme prematurity–moving beyond gestational age. N Engl J Med. 2008;358:1672–81.

    Article  CAS  Google Scholar 

  6. Marrs CC, Pedroza C, Mendez-Figueroa H, Chauhan SP, Tyson JE. Infant outcomes after periviable birth: external validation of the neonatal research network estimator with the BEAM trial. Am J Perinatol. 2015;33:569–76.

    Article  Google Scholar 

  7. Marlow N. Measuring neurodevelopmental outcome in neonatal trials: a continuing and increasing challenge. Arch Dis Child Fetal Neonatal Ed. 2013;98:F554–8.

    Article  Google Scholar 

  8. Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O’Shea TM, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. New Engl J Med. 2008;359:1885–96.

    Article  CAS  Google Scholar 

  9. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344:1966–72.

    Article  CAS  Google Scholar 

  10. Schmidt B, Roberts R, Davis P, Doyle L, Barrington K, Ohlsson A, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357:1893–902.

    Article  CAS  Google Scholar 

  11. Kilbride HW, Aylward GP, Doyle LW, Singer LT, Lantos J. Prognostic neurodevelopmental testing of preterm infants: do we need to change the paradigm? J Perinatol. 2017;37:475–9.

    Article  CAS  Google Scholar 

  12. Munck P, Niemi P, Lapinleimu H, Lehtonen L, Haataja L, Group PS. Stability of cognitive outcome from 2 to 5 years of age in very low birth weight children. Pediatrics. 2012;129:503–8.

    Article  Google Scholar 

  13. Ross G, Lipper EG, Auld PA. Consistency and change in the development of premature infants weighing less than 1,501 grams at birth. Pediatrics. 1985;76:885–91.

    CAS  PubMed  Google Scholar 

  14. Bode MM, D’Eugenio DB, Mettelman BB, Gross SJ. Predictive validity of the Bayley, Third Edition at 2 years for intelligence quotient at 4 years in preterm infants. J Dev Behav Pediatr. 2014;35:570–5.

    Article  Google Scholar 

  15. Spencer-Smith MM, Spittle AJ, Lee KJ, Doyle LW, Anderson PJ. Bayley-III cognitive and language scales in preterm children. Pediatrics. 2015;135:e1258–65.

    Article  Google Scholar 

  16. dos Santos E, de Kieviet J, Konigs M, van Elburg R, Oosterlaan J. Predictive value of the Bayley scales of infant development on development of very preterm/very low birth weight children: a meta-analysis. Early Hum Dev. 2013;89:487–96.

    Article  Google Scholar 

  17. Hack M, Taylor HG, Drotar D, Schluchter M, Cartar L, Wilson-Costello D, et al. Poor predictive validity of the Bayley scales of infant development for cognitive function of extremely low birth weight children at school age. Pediatrics. 2005;116:333–41.

    Article  Google Scholar 

  18. Yudkin PL, Aboualfa M, Eyre JA, Redman CWG, Wilkinson AR. New birth-weight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev. 1987;15:45–52.

    Article  CAS  Google Scholar 

  19. Teele R, Share J. Ultrasonography of Infants and Children. Philadelphia: Saunders; 1991.

    Google Scholar 

  20. Kuban K, Adler I, Allred EN, Batton D, Bezinque S, Betz BW, et al. Observer variability assessing US scans of the preterm brain: the ELGAN study. Pediatr Radiol. 2007;37:1201–8.

    Article  Google Scholar 

  21. San Antonio TX, Elliott CD. Differential Ability Scales. 2nd ed. San Antonio, TX: The Psychological Corporation; 2007.

    Google Scholar 

  22. Korkman M, Kirk U, Kemp SL. NEPSY-II: Clinical and Interpretive Manual. 2nd ed. Pearson Education, Inc: London, UK; 2007.

  23. Heeren T, Joseph RM, Allred EN, O’Shea TM, Leviton A, Kuban KCK. Cognitive functioning at age 10 years among children born extremely preterm: a latent profile approach. Pediatr Res. 2017;82:1201–16.

    Article  Google Scholar 

  24. Fowlie PW. Towards safer diagnosis in clinical practice–understanding and using diagnostic tests in the neonatal unit more appropriately. Semin Fetal Neonatal Med. 2005;10:83–90.

    Article  Google Scholar 

  25. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–23.

    Article  CAS  Google Scholar 

  26. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56:1129–35.

    Article  Google Scholar 

  27. Bradley-Johnson S. Cognitive assessment for the youngest children: a critical review of tests. J Psychoeduc Assess. 2001;19:19–44.

    Article  Google Scholar 

  28. Goldstein D, Folgle E, Weiber J, O’Shea T. Comparison of the Bayley scales of infant development 2nd ed. Bayley Scales Infant Dev premature Infants J Psychoed Assess. 1995;13:391–6.

    Article  Google Scholar 

  29. Lowe JR, Erickson SJ, Schrader R, Duncan AF. Comparison of the Bayley II mental developmental index and the Bayley III cognitive scale: are we measuring the same thing? Acta Paediatr. 2012;101:E55–E8.

    Article  Google Scholar 

  30. Black MM, K Matula. Essentials of Bayley Scales of Infant Development l-II Assessment. John Wiley & Sons, Inc.: New York, NY; 2000.

  31. Orchinik LJ, Taylor HG, Espy KA, Minich N, Klein N, Sheffield T, et al. Cognitive outcomes for extremely preterm/extremely low birth weight children in kindergarten. J Int Neuropsychol Soc. 2011;17:1067–79.

    Article  Google Scholar 

  32. Pugh SJ, Richardson GA, Hutcheon JA, Himes KP, Brooks MM, Day NL, et al. Maternal obesity and excessive gestational weight gain are associated with components of child cognition. J Nutr. 2015;145:2562–9.

    Article  CAS  Google Scholar 

  33. Kuban KJ, R M, O’Shea TM, Allred EN, Heeren T, Douglass L, Stafstrom CE, Jara H, Frazier JA, Hirtz D, Leviton A. Extremely low gestational age newborn (ELGAN) study investigators girls and boys born before 28 weeks gestation: risks of cognitive, behavioral, and neurological outcomes at age 10 years. J Pediatr. 2016;173:69–75.e1.

    Article  Google Scholar 

  34. Roberts G, Anderson PJ, Doyle LW. The stability of the diagnosis of developmental disability between ages 2 and 8 in a geographic cohort of very preterm children born in 1997. Arch Dis Child. 2010;95:786–90.

    Article  CAS  Google Scholar 

  35. Kuban KC, Joseph RM, O’Shea TM, Allred EN, Heeren T, Douglass L, et al. Girls and boys born before 28 weeks gestation: risks of cognitive, behavioral, and neurologic outcomes at age 10 years. J Pediatr. 2016;173:69–75 e1.

    Article  Google Scholar 

  36. Stevenson DK, Verter J, Fanaroff AA, Oh W, Ehrenkranz RA, Shankaran S, et al. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed. 2000;83:F182–5.

    Article  CAS  Google Scholar 

  37. Streimish IG, Ehrenkranz RA, Allred EN, O’Shea TM, Kuban KCK, Paneth N, et al. Birth weight- and fetal weight-growth restriction: Impact on neurodevelopment. Early Hum Dev. 2012;88:765–71.

    Article  Google Scholar 

  38. O’Shea TM, Kuban KCK, Allred EN, Paneth N, Pagano M, Dammann O, et al. Neonatal cranial ultrasound lesions and developmental delays at 2 years of age among extremely low gestational age children. Pediatrics. 2008;122:E662–9.

    Article  Google Scholar 

  39. Whitaker AH, Feldman JF, Lorenz JM, Shen S, McNicholas F, Nieto M, et al. Motor and cognitive outcomes in nondisabled low-birth-weight adolescents - Early determinants. Arch Pediatr Adolesc Med. 2006;160:1040–6.

    Article  Google Scholar 

  40. van der Burg JW, Allred EN, Kuban K, O’Shea TM, Dammann O, Leviton A. Maternal obesity and development of the preterm newborn at 2 years. Acta Paediatr. 2015;104:900–3.

    Article  Google Scholar 

  41. Watkins S, Jonsson-Funk M, Brookhart MA, Rosenberg SA, O’Shea TM, Daniels J. Preschool motor skills following physical and occupational therapy services among non-disabled very low birth weight children. Matern Child Health J. 2014;18:821–8.

    Article  Google Scholar 

  42. Juul SE, Mayock DE, Comstock BA, Heagerty PJ. Neuroprotective potential of erythropoietin in neonates; design of a randomized trial. Matern Health Neonatol Perinatol. 2015;1:27.

    Article  Google Scholar 

  43. Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, et al. Randomized trial of late surfactant treatment in ventilated preterm infants receiving inhaled nitric oxide. J Pediatr. 2016;168:23–9 e4.

    Article  CAS  Google Scholar 

  44. Vaucher YE, Peralta-Carcelen M, Finer NN, Carlo WA, Gantz MG, Walsh MC, et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367:2495–504.

    Article  CAS  Google Scholar 

  45. Silveira RC, Filipouski G, Goldstein D, O’Shea T, Procianoy R. Agreement between Bayley scales second and third edition assessments of very low birth weight infants. Arch Pediatr Adolesc Med. 2012;166:1075–6.

    Article  Google Scholar 

  46. Anderson PJ, De Luca CR, Hutchinson E, Roberts G, Doyle LW. Underestimation of developmental delay by the new Bayley-III scale. Arch Pediatr Adolesc Med. 2010;164:352–6.

    Article  Google Scholar 

  47. Johnson S, Moore T, Marlow N. Using the Bayley-III to assess neurodevelopmental delay: which cut-off should be used? Pediatr Res. 2014;75:670–4.

    Article  Google Scholar 

  48. Aylward GP. Continuing issues with the Bayley-III: where to go from here. J Dev Behav Pediatr. 2013;34:697–701.

    Article  Google Scholar 

  49. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. J Am Med Assoc. 2012;307:275–82.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the National Institute of Neurological Disorders and Stroke (Grant Nos. 5U01NS040069-05 and 2R01NS040069-09) and the Office of the Director of the National Institutes of Health (1UG3OD023348-01). We also gratefully acknowledge the contributions of their subjects, and their subjects’ families, as well as those of their colleagues listed below. This study was supported by from the Office of the Director, National Institutes of Health (1UG3OD023348-01), the National Institute of Neurological Disorders and Stroke (5U01NS040069-05 and 2R01NS040069-09), and the National Institute of Child Health and Human Development (5P30HD018655-28). Dr. Frazier has the following disclosures: serving on the data safety monitoring board for Forest Pharmaceuticals and receiving research support from Alcobra, Janssen Pharmaceuticals, Neuren, and SyneuRX International.

ELGAN Study Investigators

Bhahvesh Shah, Rachana Singh, Linda Van Marter, Camilla Martin, Janice Ware, Cynthia Cole, Ellen Perrin, Frank Bednarek, Jean Frazier, Richard Ehrenkranz, Jennifer Benjamin, T. Michael O’Shea, Carl Bose, Diane Warner, Steve Engelke, Mariel Poortenga, Steve Pastyrnak, Padu Karna, Nigel Paneth, Madeleine Lenski, Michael Schreiber, Scott Hunter, Michael Msall, Danny Batton, Judith Klarr, Karen Christianson, Deborah Klein, Maureen Pimental, Collen Hallisey, Taryn Coster, Ellen Nylen, Emily Neger, Kathryn Mattern, Lauren Venuti, Beth Powers, Ann Foley, Joanne Williams, Elaine Romano, Debbie Hiatt, Nancy Peters, Patricia Brown, Emily Ansusinha, Gennie Bose, Janice Wereszczak, Janice Bernhardt, Joan Adams, Donna Wilson, Nancy Darden-Saad, Dinah Sutton, Julie Rathbun, Karen Miras, Deborah Weiland, Grace Yoon, Rugile Ramoskaite, Suzanne Wiggins, Krissy Washington, Ryan Martin, Barbara Prendergast, Beth Kring, Anne Smith, Susan McQuiston, Samantha Butler, Rachel Wilson, Kirsten McGhee, Patricia Lee, Aimee Asgarian, Anjali Sadhwani, Brandi Henson, Cecelia Keller, Jenifer Walkowiak, Susan Barron, Alice Miller, Brian Dessureau, Molly Wood, Jill Damon-Minow, Elaine Romano, Linda Mayes, Kathy Tsatsanis, Katarzyna Chawarska, Sophy Kim, Susan Dieterich, Karen Bearrs, Ellen Waldrep, Jackie Friedman, Gail Hounshell, Debbie Allred, Rebecca Helms, Lynn Whitley, Gary Stainback, Lisa Bostic, Amanda Jacobson, Joni McKeeman, Echo Meyer, Steve Pastyrnak, Joan Price, Megan Lloyd, Susan Plesha-Troyke, Megan Scott, KatherineM. Solomon, Kara Brooklier, Kelly Vogt.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Thomas M. O’Shea.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Shea, T.M., Joseph, R.M., Allred, E.N. et al. Accuracy of the Bayley-II mental development index at 2 years as a predictor of cognitive impairment at school age among children born extremely preterm. J Perinatol 38, 908–916 (2018). https://doi.org/10.1038/s41372-017-0020-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-017-0020-8

This article is cited by

Search

Quick links